Pharvaris (PHVS) Free Cash Flow (2020 - 2026)
Pharvaris (PHVS) posted Free Cash Flow of -$57.0 million for Q1 2026, down 29.1% on a QoQ basis from -$44.2 million in Q4 2025, and down 41.52% year-over-year from -$97.5 million in Q1 2025.
Pharvaris (PHVS) Free Cash Flow (2020 - 2026) Analysis & Trends
Pharvaris' Free Cash Flow history runs 7 years deep, the most recent figure standing at -$57.0 million for Q1 2026.
- Quarterly Free Cash Flow fell 41.52% year-over-year to -$57.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$171.0 million (down 19.21% YoY) and the FY2025 annual result came in at -$154.7 million, down 19.5% from the prior year.
- Free Cash Flow was -$57.0 million for Q1 2026 at Pharvaris, down from -$44.2 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $49676.0 billion in Q3 2023 and bottomed at -$49691.2 billion in Q2 2023.
- A 5-year average of -$926.4 million and a median of -$29.8 million in 2024 frame the typical range for Free Cash Flow.
- Peak annual rise in Free Cash Flow reached 325629580.06% in 2023, while the deepest fall reached 340811256.1% in 2023.
- Pharvaris' Free Cash Flow stood at -$20.8 million in 2022, then fell by 23.0% to -$25.6 million in 2023, then tumbled by 45.31% to -$37.2 million in 2024, then slipped by 18.82% to -$44.2 million in 2025, then dropped by 29.1% to -$57.0 million in 2026.
- Business Quant data shows PHVS's Free Cash Flow at -$57.0 million in Q1 2026, -$44.2 million in Q4 2025, and -$35.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Pharvaris | 2.17 Bn | 1.88 Bn | - | -57.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -57.03 Mn |
| Mar 31, 2026 | -57.03 Mn |
| Dec 31, 2025 | -44.18 Mn |
| Dec 31, 2025 | -44.18 Mn |
| Sep 30, 2025 | -35.83 Mn |
| Sep 30, 2025 | -35.83 Mn |
| Jun 30, 2025 | -33.96 Mn |
| Jun 30, 2025 | -33.96 Mn |
| Mar 31, 2025 | -40.30 Mn |
| Mar 31, 2025 | -40.30 Mn |
| Dec 31, 2024 | -37.18 Mn |
| Dec 31, 2024 | -37.18 Mn |
| Sep 30, 2024 | -36.19 Mn |
| Sep 30, 2024 | -36.19 Mn |
| Jun 30, 2024 | -29.77 Mn |
| Jun 30, 2024 | -29.77 Mn |
| Mar 31, 2024 | -26.29 Mn |
| Mar 31, 2024 | -26.29 Mn |
| Dec 31, 2023 | -25.59 Mn |
| Dec 31, 2023 | -25.59 Mn |